Morphine methylbromide

Morphine methylbromide

Clinical data
Other names	Morphine bromomethylate; Morphine methobromide; Morphosan
Legal status
Legal status	UK: Class A US: Schedule I
Identifiers
IUPAC name (5α,6α)-3,6-Dihydroxy-17,17-dimethyl-7,8-didehydro-4,5-epoxymorphinan-17-ium bromide
CAS Number	125-23-5
PubChem CID	5362445
ChemSpider	4515037
UNII	1A51P5NGGU
CompTox Dashboard (EPA)	DTXSID90924983
Chemical and physical data
Formula	C18H22BrNO3
Molar mass	380.282 g·mol−1
3D model (JSmol)	Interactive image
SMILES [H][C@]1([C@@H](O)C=C2)[C@]([C@]2([H])[C@H]3C4)(CC[N+]3(C)C)C5=C4C=CC(O)=C5O1.[Br-]
InChI InChI=1S/C18H21NO3.BrH/c1-19(2)8-7-18-11-4-6-14(21)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19;/h3-6,11-12,14,17,21H,7-9H2,1-2H3;1H/t11-,12+,14-,17-,18-;/m0./s1 Key:KQUQZJSQMSHWHP-SCLAZZCHSA-N

Morphine methylbromide (morphine methobromide, morphine bromomethylate, morphosan) a derivative of morphine. It is a narcotic opioid listed as a Schedule I controlled substance with an ACSCN of 9305 and a 2014 aggregate national production quota of 5 grams. It is a quaternary ammonium salt formed by reaction of morphine with methyl bromide.^[1][2]